3-甲氧基-4-(4-甲基-1H-咪唑-1-基)苯胺 → N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-4-methyl-2-(pyridin-3-yl)-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amine

HRID 12

反应方程式

HRID 12 反应方程式
CN1Cc2ccc(Cl)nc2OC(c2cccnc2)C1.COc1cc(N)ccc1-n1cnc(C)c1>CC(=O)O.CC(=O)O.COCCOC.O=C([O-])[O-].[Cs+].[Cs+].[Pd].c1ccc(-c2ccccc2P(C2CCCCC2)C2CCCCC2)cc1>COc1cc(Nc2ccc3c(n2)OC(c2cccnc2)CN(C)C3)ccc1-n1cnc(C)c1

参与物

7

反应物 2

HCID 454801813-甲氧基-4-(4-甲基-1H-咪唑-1-基)苯胺HCID 595778128-Chloro-4-methyl-2-(pyridin-3-yl)-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine

产物 1

HCID 49821014N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-4-methyl-2-(pyridin-3-yl)-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amine收率 27.8%

试剂、催化剂与溶剂 4

HCID 10796碳酸氢铯试剂HCID 27342162-(二环己基膦基)联苯催化剂HCID 4144353醋酸钯催化剂HCID 8071乙二醇二甲醚溶剂

反应条件

温度
100 °C

实验过程

[Reactants], Palladium(II) acetate (5.29 mg, 0.02 mmol), 2-(Dicyclohexylphosphino)biphenyl (8.26 mg, 0.02 mmol) and Cesium carbonate (0.230 g, 0.71 mmol) were placed in a microwave vial and flushed with argon. DME (2 mL) was added and the reaction mixture was run in the microwave at 100°C for 60 minutes. Reaction not complete. Added 0.1 eq of Palladium(II) acetate (5.29 mg, 0.02 mmol) and 0.1 eq of 2-(Dicyclohexylphosphino)biphenyl (8.26 mg, 0.02 mmol) and flushed with argon. Run in the microwave at 100°C for 60 minutes and the reaction was complete. The reaction mixture was filtrated through celite and concentrated. The crude product was purified by prep-HPLC. The solvent was evaporated and partitioned between sat. NaHCO3 and dichloromethane. The organic layer was separated, dried (MgSO4) and concentrated giving 0.029 g (28%) of the product.

来源与证据

ORD记录
ord-373fd601db1247b0b18c34bca387c3a4
来源数据集
750 AstraZeneca ELN dataset
原始链接
查看来源

关联笔记

加载中…